Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
celgene
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
nash
2
×
national
2
×
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sanofi
2
×
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
2019
acc
acquisition
activism
activist investor
acute hepatic porphyria
aducanumab
alnylam pharmaceuticals
alzheimer's failure
What
bio
drug
roundup
adu
advanced
alnylam’s
approval
approved
beats
bff
bids
biogen
complicated
conference
deals
depression
devoted
dire
disease
easl
form
gene
good
group
heart
help
kicked
liver
major
medical
need
news
people
postpartum
race
relief
sage
therapy
treat
updates
Language
Current search:
nash
×
national
×
sanofi
×
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More